Agenda

Matt Tobelmann is the Director of Business Operations for Engineering, AI / Data Science, and IT teams at Verily — a precision health company building platform solutions that bring the promise of precision health to everyone, every day.  Matt leads the optimization of product development processes, business intelligence, financial / organizational forecasting within Verily’s Technology organization. Previously, Matt led Strategy and Operations teams at Google and advised Fortune 500 companies in pharma, aerospace, and fintech as a manager at McKinsey.  He started his career as a Product Manager and Presidential Management Fellow in the U.S. Department of Defense Chemical and Biological Defense Program.  Matt holds a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison and a B.S from Iowa State University.

Neal Batra is a principal in Deloitte’s Life Sciences and Health Care industry and heads Deloitte’s market-leading Future of Health™ practice, which focuses on business model and operating model innovation, re-design, and transformation in the face of radical industry change.  Neal’s work puts into practice the award-winning ideas that anchor the Future of Health point-of-view that he co-authored in 2018 and built upon over the past 7 years.  Neal has over 22 years of experience advising Health organizations on critical strategic challenges, serving clients across the ecosystem, including biotech, medtech, health insurers, hospitals, health retailers and consumer health businesses. He is also the  Lead Alliance partner for Deloitte’s global relationship with the world-class, Israel-based hospital Sheba Tel Hashomer, as well as the Convergence lead for the Life Sciences & Health Care Industry practice.  Neal lives in the Bay Area, California with his fiancée Morgan and dog Aspen.  He holds an MBA from London Business School and a BBA from the College of William and Mary.

Tobias is a San-Francisco based investor with Mubadala Capital. He supports new venture builds and has invested in early-stage therapeutics companies focused on neuroscience, genomic medicine delivery, AI drug design, ophthalmology, oncology, immunology, and cardiovascular diseases. He has held several roles in the biotech space, including Swanson Fellow at The Column Group, and Expert in Residence at the Berkeley Life Sciences Entrepreneurship Center.  He was a founding member of the Bay Area chapter of Nucleate where he helped launch a student-led incubator at Berkeley, UCSF, and Stanford. Tobias is committed to improving opportunities for students from underserved groups in STEM to support economic advancement through workforce development. He runs a mentorship and internship program for high school and community college students who are interested in pursuing careers in the life sciences. Tobias has a PhD in Neuroscience from the University of California, Berkeley. He graduated with a B.S. in Neuroscience and B.A. in Spanish from the University of Florida.

Matt Krisiloff is CEO of Conception, a company working on turning pluripotent stem cells into viable human eggs. Previously, he was the director of Y Combinator Research, the research non-profit of Y Combinator. He was also a founding team member of OpenAI, and has worked with over 150 startups as both an investor and advisor.

Renee Yao is the director of ecosystem business development for healthcare life sciences at NVIDIA, where she focuses on scaling partners and startups — who are critical for expediting ecosystem go-to-market strategies and adopting the NVIDIA platform. While managing a diverse portfolio, she also oversees over 4000 healthcare startups in segments such as digital health, medical instruments, medical imaging, genomics, and drug discovery. Previously, Yao worked in product management for NVIDIA’s AI systems, shaping bundle solutions and reference architectures for self-driving cars, telecommunications, and big data analytics industries. Outside of NVIDIA, Yao has founded a few startups in various areas including healthcare insurance, and more. She graduated from UC Berkeley, with a focus on business, economics and IT, and completed Berkeley CEO Program.

Andrea is a visionary entrepreneur and the Co-founder of OncoSwab. Selected as a top 100 young scientist in Europe, she stumbled upon a cancer screening idea that led her to start her first diagnostic company at the age of 24. Andrea pursued a Master’s degree in molecular biotechnology with a goal of making an impact in global health. Today, lung cancer is the leading cause of cancer death in the world, fueling Andrea's strategic vision for early detection with OncoSwab. 

Chuka Esiobu is a Principal at Define Ventures — one of the largest early stage (Inception to Series B) venture capital firms focused on health tech and pharma tech. Prior to Define, Chuka’s experiences spanned management consulting (BCG), operating (Evolent Health), and venture investing (Bessemer). At Evolent Health, Chuka was an Associate Director on the 0 to 1 team where he built solutions for ACOs and health systems under value based care contracts. He began his career at The Boston Consulting Group focused on corporate development and strategy for biopharma clients, amongst others. Chuka earned a B.A. degree from Harvard University with a concentration in Neurobiology and a secondary in Economics. He received his MBA from The Wharton School.

Ken is responsible for product growth and GTM within Cloud Applied AI for Healthcare & Risk AI industries. He helps teams tailor the latest AI innovations for provider, payer, and life science / med device companies. He previously worked on healthcare features within Google Search (appointment booking, provider directory, mental health) and started at Google by applying early AI/ML research models in medical imaging, medical scribe, and Google 4 Clinicians. Prior to Google, Ken advised biotech/pharma companies at ZS Associates and was an early employee at Omada Health, with stints at Castlight, UCSF, and Kaiser Permanente. Ken has a MBA/MPH from UC Berkeley and a BBA from UofMichigan.

Stephanie Ledesma is Kaiser Permanente’s Senior Vice President of Community and Social Health. In her role, she oversees strategic initiatives, operations and continuous improvement initiatives across Kaiser Permanente’s annual $3+ billion Community Health portfolio. She is responsible for the development and implementation of key strategies focused on addressing social factors of health for both members and individuals in the communities we serve.  She further ensures all resources deployed drive value for communities and members in alignment with KP’s mission.

Previously, Stephanie was Chief Operating Officer of Aetna Better Health of Pennsylvania, where she was responsible for optimizing operations of the Medicaid business and leading the successful shift from fee-for-service contracts to value-based arrangements. She led collaboration efforts with community organizations to break cycles of poverty and food insecurity.

Prior to Aetna, Stephanie served as Magellan Complete Care’s Chief Technology Officer, notably implementing Florida’s first and only Medicaid specialty plan for individuals with Serious Mental Illness, and New York’s Fully Integrated Duals Advantage program.  Additionally, she was accountable for Information Technology and operations for all strategic business units.

Recognized by the Governor’s office as one of Pennsylvania’s top 100 most influential Latino leaders, she holds a master’s degree in applied Analytics from Saint Louis University and graduated summa cum laude with a Bachelor of Science in Information Technology from Lindenwood University.

Inder is the founder and former CEO of Kinsa, which pioneered the smart thermometer and built a 5M-user consumer business, alongside an SaaS platform serving 100+ enterprises. Previously, he was EVP at the Clinton Health Access Initiative, where he brokered agreements between companies and governments that reduced drug costs by 90%, saving over $1B for global health programs. He holds degrees from Michigan, Harvard, and MIT, has 21 patents, is an Entrepreneur in Residence at UC Berkeley, and a member of the Council on Foreign Relations. Today, he advises and coaches founders, helping them navigate the toughest challenges in leadership and company building.

Whittney Tom (she/her) is a global health practitioner with over 15 years of experience building equitable partnerships to drive sustainable health outcomes. She started her career at a community clinic in coastal Kenya, where she learned the importance of listening and collaboration in tackling health challenges. Whittney later contributed to cross-border humanitarian response efforts in the Middle East before transitioning to work with the private sector while at TechSoup and Meta (formerly Facebook). Today, as Senior Director of Business Development at the Sabin Vaccine Institute, she focuses on fostering multisectoral partnerships and financing models to ensure sustainable, country-owned solutions.